Rec­om­men­da­tions

9.1 Most peo­ple with type 1 di­a­betes should be treat­ed with mul­ti­ple daily in­jec­tions of pran­di­al and basal in­sulin, or con­tin­u­ous sub­cu­ta­neous in­sulin in­fu­sion. A

9.2 Most in­di­vid­u­als with type 1 di­a­betes should use rapid-‍act­ing in­sulin ana­logs to re­duce hy­po­glycemia risk. A

9.3 Con­sid­er ed­u­cat­ing in­di­vid­u­als with type 1 di­a­betes on match­ing pran­di­al in­sulin doses to car­bo­hy­drate in­take, pre­meal blood glu­cose lev­els, and an­tic­i­pat­ed phys­i­cal ac­tiv­i­ty. E

9.4 In­di­vid­u­als with type 1 di­a­betes who have been suc­cess­ful­ly using con­tin­u­ous sub­cu­ta­neous in­sulin in­fu­sion should have con­tin­ued ac­cess to this ther­a­py after they turn 65 years of age. E